ELISPOT analysis of hepatitis C virus protein-specific IFN-γ-producing peripheral blood lymphocytes in infected humans with and without cirrhosis

Clinical Immunology and Immunopathology

Volumn 99, Issue 2, 2001, Pages 232-240

  Anthony, Donald D ^a,b   Post, Anthony B ^a,b   Valdez, Hernan ^b   Peterson, Darrell L ^c   Murphy, Madeleine ^b   Heeger, Peter S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cellular; Cytokine; Hepatitis C; Human; Immunity; T cell

Indexed keywords

CORE PROTEIN; GAMMA INTERFERON; HEPATITIS C ANTIGEN; VIRUS PROTEIN;

ARTICLE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LIVER CIRRHOSIS; METHODOLOGY; PROGNOSIS; T LYMPHOCYTE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; LIVER CIRRHOSIS; PROGNOSIS; T-LYMPHOCYTES; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 16344367898     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5018     Document Type: Article

References (15)

1. Koziel, M. J., Immunology of viral hepatitis. Am. J. Med. 100, 98, 1996.
2. Gross, J. B., Jr., Clinician's guide to hepatitis C. Mayo Clin. Proc. 73, 355, 1998.
3. Management of hepatitis C (consensus conference). Hepatology 26(Suppl. 1), Is, 1997.
4. Seeff, L., Buskell-Bales, Z., Wright, E., Durako, S., Alter, H., Iber, F., Hollinger, F., Gitnick, G., Knodell, R., Perillo, R., Stevens, C., and Hollingsworth, C., Long-term mortality after transfusion-associated non-A, non-B hepatitis. N. Engl. J. Med. 327, 1906, 1992.
5. Tong, M., El-Farra, N., Reikes, A., and Co, R., Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332, 1463, 1995.
6. Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hurter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., and Haussinger, D., Prognosis of chronic hepatitis C: Results of a large prospective cohort study. Hepatology 28, 1687, 1998.
7. Nelson, D. R., Marousis, C. G., Davis, G. L., Rice, C. M., Wong, J., Houghton, M., and Lau, J. Y. N., The role of hepatitis C virusspecific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158, 1473, 1997.
8. Ferrari, C., Valli, A., Galati, L., Penna, A., Scaccaglia, P., Giuberti, T., Schianchi, C., Missale, G., Marin, M. G., and Fiaccadori, F., T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19, 286, 1994.
9. Botarelli, P., Brunetto, M. R., Minutello, M. A., Calvo, P., Unutmaz, D., Weiner, A. J., Choo, Q., Shuster, J. R., Kuo, G., Bonino, F., Houghton, M., and Abrignani, S., T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104, 580, 1993.
10. Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M., Houghton, M., Fiaccadori, F., and Ferrari, C., Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cellmediated immune response. J. Clin. Invest. 98, 706, 1996.
11. Tsai, S., Liaw, Y., Chen, M., Huang, C., and Kuo, G., Detection of type 2 like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity. Hepatology 25, 449, 1997.
12. Lechmann, M., Ihlenfeldt, H. G., Braunschweiger, L, Tiers, F., Jung, G., Matz, B., Kaiser, R., Sauerbruch, T., and Spengler, U., T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy antihepatitis C virus positive blood donors without viremia. Hepatology 24, 790, 1996.
13. + T-cell response in acute hepatitis C. Gastroenterology 117, 933, 1999.
14. Rosen, H. R., Hinrichs, D. J., Gretch, D. R., Koziel, M. J., Chou, S., Houghton, M., Rabkin, J., Corless, C. L., and Bouwer, H. G. A., Association of multispecific CD4 response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 117, 926, 1999.
15. Jin, Y., Fuller, L., Carreno, M., Zucker, K., Roth, D., Esquenazi, V., Karatzas, T., Swanson, S. J., III, Tzakis, A. G., and Miller, J., The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage. J. Clin. Immunol. 17, 140, 1997.